1. Home
  2. ASMB vs CBAN Comparison

ASMB vs CBAN Comparison

Compare ASMB & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.57

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$19.74

Market Cap

436.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
CBAN
Founded
2005
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
436.3M
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
ASMB
CBAN
Price
$28.57
$19.74
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$43.40
N/A
AVG Volume (30 Days)
91.6K
161.1K
Earning Date
01-01-0001
04-29-2026
Dividend Yield
N/A
2.42%
EPS Growth
50.00
9.68
EPS
N/A
1.17
Revenue
N/A
N/A
Revenue This Year
$33.33
$35.41
Revenue Next Year
N/A
$4.84
P/E Ratio
N/A
$16.97
Revenue Growth
N/A
N/A
52 Week Low
$7.76
$13.99
52 Week High
$39.71
$21.46

Technical Indicators

Market Signals
Indicator
ASMB
CBAN
Relative Strength Index (RSI) 49.61 47.08
Support Level $26.50 $15.96
Resistance Level $31.11 $21.25
Average True Range (ATR) 1.84 0.61
MACD 0.11 -0.14
Stochastic Oscillator 57.55 30.08

Price Performance

Historical Comparison
ASMB
CBAN

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

Share on Social Networks: